Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colonic Neoplasms 66Rectal Neoplasms 61Colorectal Neoplasms 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Neoplasm Metastasis 12Lymphoma 12Burkitt Lymphoma 11Leukemia 9Unspecified Adult Solid Tumor, Protocol Specific 7Lymphoma, Non-Hodgkin 6Leukemia, Biphenotypic, Acute 6Carcinoma, Hepatocellular 6Stomach Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Gallbladder Neoplasms 5Bile Duct Neoplasms 5Acquired Immunodeficiency Syndrome 5Neoplasms 4HIV Infections 4Osteosarcoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3Esophageal Neoplasms 3Sarcoma 2Ovarian Neoplasms 2Neoplasms, Unknown Primary 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2

Interventions

Specimen Handling 10Magnetic Resonance Spectroscopy 9Carboplatin 9Taxes 7Paclitaxel 7Biopsy 7temsirolimus 6Trastuzumab 5Sirolimus 5pembrolizumab 4Radiotherapy 4olaparib 3Nivolumab 3Interleukin-12 Subunit p35 3Bevacizumab 3pertuzumab 2palbociclib 2ipatasertib 2binimetinib 2aldesleukin 2X-Rays 2Thalidomide 2Reverse Transcriptase Polymerase Chain Reaction 2Oxaliplatin 2Megestrol Acetate 2Interleukin-12 2Immunoglobulin G 2Fluorouracil 2Docetaxel 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Endometrial Neoplasms × Leucovorin × Clear all
NCT05564377 2026-06-02

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

National Cancer Institute (NCI)

Phase 2 Recruiting
2,900 enrolled
Gynecologic

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡